The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Activated ALK Collaborates with MYCN in Neuroblastoma Pathogenesis
Open accessAbstract
SUMMARY Amplification of the MYCN oncogene in childhood neuroblastoma is often accompanied by mutational activation of ALK (anaplastic lymphoma kinase), suggesting their pathogenic cooperation. We generated a transgenic zebrafish model of neuroblastoma in which MYCN-induced tumors arise from a subpopulation of neuroblasts that migrate into the adrenal medulla analogue following organogenesis. Coexpression of activated ALK with MYCN in this model triples the disease penetrance and markedly accelerates tumor onset. MYCN overexpression induces adrenal sympathetic neuroblast hyperplasia, blocks chromaffin cell differentiation, and ultimately triggers a developmentally-timed apoptotic response in the hyperplastic sympathoadrenal cells. Coexpression of activated ALK with MYCN provides prosurvival signals that block this apoptotic response and allow continued expansion and oncogenic transformation of hyperplastic neuroblasts, thus promoting progression to neuroblastoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stages of embryonic development of the zebrafish
Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B., & Schilling, T. F. (1995) · Developmental Dynamics · doi:10.1002/aja.1002030302 · Cited by 12,037
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Kwak, E. L., Bang, Y.-J., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S.-H. I., Dezube, B. J., Jänne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,446
High-resolution in situ hybridization to whole-mount zebrafish embryos
Thisse, C., & Thisse, B. (2008) · Nature Protocols · doi:10.1038/nprot.2007.514 · Cited by 2,578
Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma
Morris, S. W., Kirstein, M. N., Valentine, M. B., Dittmer, K. G., Shapiro, D. N., Saltman, D. L., & Look, A. T. (1994) · Science · doi:10.1126/science.8122112 · Cited by 2,409
Self-citationNeuroblastoma: biological insights into a clinical enigma
Brodeur, G. M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1014 · Cited by 2,160
Maris, J. M., Hogarty, M. D., Bagatell, R., & Cohn, S. L. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60983-0 · Cited by 2,032
Recent Advances in Neuroblastoma
Maris, J. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0804577 · Cited by 1,983
Identification of ALK as a major familial neuroblastoma predisposition gene
Mossé, Y. P., Laudenslager, M., Longo, L., Cole, K. A., Wood, A., Attiyeh, E. F., Laquaglia, M. J., Sennett, R., Lynch, J. E., Perri, P., et al. (2008) · Nature · doi:10.1038/nature07261 · Cited by 1,407
Guillemot, F., Lo, L.-C., Johnson, J. E., Auerbach, A., Anderson, D. J., & Joyner, A. L. (1993) · Cell · doi:10.1016/0092-8674(93)90381-y · Cited by 1,033
Oncogenic mutations of ALK kinase in neuroblastoma
Chen, Y., Takita, J., Choi, Y. L., Kato, M., Ohira, M., Sanada, M., Wang, L., Soda, M., Kikuchi, A., Igarashi, T., et al. (2008) · Nature · doi:10.1038/nature07399 · Cited by 916
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Janoueix-Lerosey, I., Lequin, D., Brugières, L., Ribeiro, A., de Pontual, L., Combaret, V., Raynal, V., Puisieux, A., Schleiermacher, G., Pierron, G., et al. (2008) · Nature · doi:10.1038/nature07398 · Cited by 894
Activating mutations in ALK provide a therapeutic target in neuroblastoma
George, R. E., Sanda, T., Hanna, M., Fröhling, S., II, W. L., Zhang, J., Ahn, Y., Zhou, W., London, W. B., McGrady, P., et al. (2008) · Nature · doi:10.1038/nature07397 · Cited by 893
Self-citationThe anaplastic lymphoma kinase in the pathogenesis of cancer
Chiarle, R., Voena, C., Ambrogio, C., Piva, R., & Inghirami, G. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2291 · Cited by 882
The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives
Pattyn, A., Morin, X., Cremer, H., Goridis, C., & Brunet, J.-F. (1999) · Nature · doi:10.1038/20700 · Cited by 875
Targeted expression of MYCN causes neuroblastoma in transgenic mice
Weiss, W. A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.11.2985 · Cited by 870
Crizotinib in ALK-Rearranged Inflammatory Myofibroblastic Tumor
Butrynski, J. E., D'Adamo, D. R., Hornick, J. L., Dal Cin, P., Antonescu, C. R., Jhanwar, S. C., Ladanyi, M., Capelletti, M., Rodig, S. J., Ramaiya, N., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007056 · Cited by 870
Self-citationCooperative interaction between c-myc and bcl-2 proto-oncogenes
Fanidi, A., Harrington, E. A., & Evan, G. I. (1992) · Nature · doi:10.1038/359554a0 · Cited by 759
Hu neuronal proteins are expressed in proliferating neurogenic cells
Marusich, M. F., Furneaux, H. M., Henion, P. D., & Weston, J. A. (1994) · Journal of Neurobiology · doi:10.1002/neu.480250206 · Cited by 484
Myc pathways provoking cell suicide and cancer
Nilsson, J. A., & Cleveland, J. L. (2003) · Oncogene · doi:10.1038/sj.onc.1207261 · Cited by 462
Anaplastic lymphoma kinase: signalling in development and disease
Palmer, R. H., Vernersson, E., Grabbe, C., & Hallberg, B. (2009) · Biochemical Journal · doi:10.1042/bj20090387 · Cited by 423
Sasaki, T., Okuda, K., Zheng, W., Butrynski, J., Capelletti, M., Wang, L., Gray, N. S., Wilner, K., Christensen, J. G., Demetri, G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2956 · Cited by 335
Self-citationDe Brouwer, S., De Preter, K., Kumps, C., Zabrocki, P., Porcu, M., Westerhout, E. M., Lakeman, A., Vandesompele, J., Hoebeeck, J., Van Maerken, T., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2660 · Cited by 279
The sympathoadrenal cell lineage: Specification, diversification, and new perspectives
Huber, K. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.07.010 · Cited by 197
Teitelman, G., Baker, H., Joh, T. H., & Reis, D. J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.509 · Cited by 190
Zebrafish foxd3 is selectively required for neural crest specification, migration and survival
Stewart, R. A., Arduini, B. L., Berghmans, S., George, R. E., Kanki, J. P., Henion, P. D., & Look, A. T. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2005.12.035 · Cited by 180
Self-citationMechanisms of embryonal tumor initiation: Distinct roles for MycN expression and MYCN amplification
Hansford, L. M., Thomas, W. D., Keating, J. M., Burkhart, C. A., Peaston, A. E., Norris, M. D., Haber, M., Armati, P. J., Weiss, W. A., & Marshall, G. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401083101 · Cited by 159
Hsu, H., Lin, G., & Chung, B. (2003) · Development · doi:10.1242/dev.00427 · Cited by 106
Molecular pathogenesis of peripheral neuroblastic tumors
Janoueix‐Lerosey, I., Schleiermacher, G., & Delattre, O. (2010) · Oncogene · doi:10.1038/onc.2009.518 · Cited by 101
Differentiation and maturation of zebrafish dorsal root and sympathetic ganglion neurons
An, M. J., Luo, R., & Henion, P. D. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10214 · Cited by 95
Lucas, M. E., Müller, F. W., Rüdiger, R., Henion, P. D., & Rohrer, H. (2006) · Development · doi:10.1242/dev.02574 · Cited by 87
Alam, G. N., Cui, H., Shi, H., Yang, L., Ding, J., Mao, L., Maltese, W. A., & Ding, H. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090019 · Cited by 83
Zebrafish Immunohistochemistry
Macdonald, R. (2003) · Humana Press eBooks · doi:10.1385/1-59259-678-9:77 · Cited by 80
O’Brien, E. K., d’Alençon, C., Bonde, G., Li, W., Schoenebeck, J. J., Allende, M. L., Gelb, B. D., Yelon, D. L., Eisen, J. S., & Cornell, R. A. (2003) · Developmental Biology · doi:10.1016/j.ydbio.2003.09.029 · Cited by 75
Co-injection strategies to modify radiation sensitivity and tumor initiation in transgenic Zebrafish
Langenau, D. M., Keefe, M., Storer, N. Y., Jette, C. A., Smith, A. C., Ceol, C. J., Bourque, C., Look, A. T., & Zon, L. I. (2008) · Oncogene · doi:10.1038/onc.2008.56 · Cited by 69
Self-citationChesler, L., & Weiss, W. A. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.011 · Cited by 60
Finch, A. J., Prescott, J. E., Shchors, K., Hunt, A. E., Soucek, L., Dansen, T. B., Swigart, L. B., & Evan, G. I. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.06.017 · Cited by 49
Development of the Peripheral Sympathetic Nervous System in Zebrafish
Stewart, R. A., Look, A. T., Kanki, J. P., & Henion, P. D. (2004) · Methods in cell biology · doi:10.1016/s0091-679x(04)76012-4 · Cited by 11
Self-citationHoshi, N., Hitomi, J., Kusakabe, T., et al. (2008) · Medical Molecular Morphology · doi:10.1007/s00795-008-0407-x · Cited by 8
Cited by
Matthay, K. K., Maris, J. M., Schleiermacher, G., Nakagawara, A., Mackall, C. L., Diller, L., & Weiss, W. A. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.78 · Cited by 1,419
Neuroblastoma: developmental biology, cancer genomics and immunotherapy
Cheung, N.-K. V., & Dyer, M. A. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3526 · Cited by 801
Huang, M., & Weiss, W. A. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014415 · Cited by 647
Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology
Hallberg, B., & Palmer, R. H. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3580 · Cited by 645
Zebrafish cancer: the state of the art and the path forward
White, R., Rose, K., & Zon, L. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3589 · Cited by 416
Metadata
- Authors
- Zhu, S., Lee, J.-S., Guo, F., Shin, J., Perez-Atayde, A. R., Kutok, J. L., Rodig, S. J., Neuberg, D. S., Helman, D., Feng, H., Stewart, R. A., Wang, W., George, R. E., Kanki, J. P., & Look, A. T.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 21
- Issue
- 3
- Pages
- 362-373
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2161954865
- Cited by
- 365
- References
- 38
- FWCI
- 14.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.